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Abstract: Due to the complexity of cancer, clustering algorithms have been
used to disentangle the observed heterogeneity and identify cancer subtypes that
can be treated specifically. While kernel based clustering approaches allow the
use of more than one input matrix, which is an important factor when con-
sidering a multidimensional/manifold disease like cancer, the clustering results
remain hard to evaluate and, in many cases, it is unclear which piece of in-
formation had which impact on the final result. In this paper, we propose an
extension of multiple kernel learning clustering that enables the characteriza-
tion of each identified patient cluster based on the features that had the highest
impact on the result. To this end, we combine feature clustering with multiple
kernel dimensionality reduction and introduce FIPPA, a score which measures
the feature cluster impact on a patient cluster.
Results: We applied the approach to different cancer types described by four
different data types with the aim of identifying integrative patient subtypes and
understanding which features were most important for their identification. Our
results show that our method does not only have state-of-the-art performance
according to standard measures (e.g., survival analysis), but, based on the high
impact features, it also produces meaningful explanations for the molecular
bases of the subtypes. This could provide an important step in the validation
of potential cancer subtypes and enable the formulation of new hypotheses con-
cerning individual patient groups. Similar analysis are possible for other disease
phenotypes.
Availability: Source code for rMKL-LPP with feature clustering and the calcu-
lation of fFIPPA scores is available at https://github.molgen.mpg.de/nora/fFIPPA.
Contact: pfeifer@informatik.uni-tuebingen.de
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1 Introduction
Despite the growing amount of multidimensional data available for cancer pa-
tients, the optimal treatment for a new patient remains in many cases unknown.
In this setting, clustering algorithms are increasingly helpful to identify cancer
subtypes, i.e., homogeneous groups of patients that could benefit from the same
treatment. Most clustering algorithms, e.g., k-means clustering (Hartigan, 1975)
or spectral clustering (von Luxburg, 2007) generate a hard clustering, i.e., each
sample is assigned to one cluster, which works well when the clusters are sep-
arated. When analyzing cancer data, samples might lie between two or more
clusters because they show characteristics of each of them. In these cases, fuzzy
or soft clustering methods give additional information, since they assign to each
patient a membership probability for each cluster instead of a binary cluster
assignment. For the purpose of soft-clustering, fuzzy c-means (Dunn, 1974;
Bezdek, 1981) extends the prominent k-means clustering method. To handle
the increasing diversity in the data describing the same sample, fuzzy c-means
can be combined with multiple kernel learning approaches, either directly as
shown by Hsin-Chien Huang et al. (2012) or via application to the result of
multiple kernel based dimensionality reduction (Speicher and Pfeifer, 2015).
However, after the process of calculating kernel matrices for the input data,
the subsequent data integration and the clustering of the samples, interpreting
the results is difficult and the crucial features usually remain obscure. This lack
of interpretability also hinders the validation of the identified groups in cases
where the ground truth is not known.
We base our approach on the assumption that sample clusters are not defined
by all features but rather by a subset of features which is also the motivation
for the technique of biclustering or co-clustering, i.e., the simultaneous cluster-
ing of samples and features (Hartigan, 1972). This assumption becomes even
more realistic with the increasing number of features within the data types, e.g.,
for DNA methylation or gene expression data, that are being measured nowa-
days for a cancer sample. Therefore, our approach combines feature clustering
with subsequent data integration and sample clustering, thereby providing sev-
eral advantages. First, the feature clustering identifies groups of homogeneous
features, as typically, even for patients in the same cluster, not all measured
features will behave similarly. Consequently, the sample similarities obtained
from each of these feature groups are less noisy than the similarities one would
obtain based on all the features. Second, due to the learned kernel weights we
are able to identify which feature clusters were especially influential for each
sample clustering allowing the further characterization of the identified sample
clusters.
Related work Data integration has been combined with clustering algo-
rithms in different ways. One approach that is regularly used for cancer data
is the so-called late integration, where clusterings are combined after they have
been retrieved for each data source independently (The Cancer Genome Atlas,
2012). However, signals that might be spread over distinct data types could be
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too weak in each data source to have an impact on the individual clustering
and therefore, might not be present in the final result. To circumvent this prob-
lem, different approaches integrate the data at an earlier time point, this way
performing intermediate integration.
iCluster creates the clustering using a joint latent variable model in which
sparsity of the features is imposed by using an l1 norm or a variance-related
penalty (Shen et al., 2012). The authors applied their approach to a dataset of
55 glioblastoma patients described by three data types. In a different approach,
Wang et al. (2014) extract the sample similarities from each data type and
generate sample similarity networks. These can then be fused iteratively by
using a message-passing algorithm until convergence to a common integrated
network.
Another possibility for data integration is multiple kernel learning whose
strength lies in its wide applicability in different scenarios, e.g., to integrate
data from arbitrary sources or to integrate distinct representations of the same
input data. Therefore, it has been combined with a number of unsupervised
algorithms in the last years. Yu et al. (2012) developed a multiple kernel ver-
sion of k-means clustering. The optimization of the weights for the conic sum of
kernels is a non-convex problem tackled by a bi-level alternating minimization
procedure. A different approach for multiview k-means combines non-linear di-
mensionality reduction based on multiple kernels with subsequent clustering of
the samples in the projection space (Speicher and Pfeifer, 2015). Kumar et al.
(2011) extend spectral clustering such that it allows the clustering based on
multiple inputs. Here, data integration is achieved by co-regularization of the
kernel matrices which enforces the cluster structures in the different matrices
to agree. Moving one step further, Go¨nen and Margolin (2014) introduced lo-
calized kernel k-means, which, instead of optimizing one weight per kernel, uses
per-sample weights to have more flexibility to account for sample-specific char-
acteristics. Some of the algorithms described have been applied to cancer data
and could show improvements, such as increased robustness to noise in individ-
ual data sources and increased flexibility of the model (Go¨nen and Margolin,
2014; Speicher and Pfeifer, 2015). However, they do not allow the extraction
of importances directly related to specific features or the interpretation of the
result on the basis of the applied algorithm, which is especially in unsupervised
learning an important step to be able to associate clusters with their specific
characteristics.
A number of approaches aim at increasing performance and interpretability
by incorporating prior knowledge. Multiview biclustering (Le Van et al., 2016)
integrates copy number variations with Boolean mutation data, which are trans-
formed into ranked matrices using a known network of molecular interactions
between the genes. The subtype identification problem is then formulated as a
rank matrix factorization of the ranked data. On breast cancer data, the method
could refine the established subtypes which are based on PAM50 classification.
Approaches similar to ours concerning the subdivision into feature groups be-
fore applying multiple kernel learning were presented by Sinnott and Cai (2018)
for supervised survival prediction of cancer patients and by Rahimi and Go¨nen
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(2018) for discriminating early- from late-stage cancers, showing a better in-
terpretability compared to standard approaches. However, in both cases the
feature groups are identified using prior knowledge (i.e., gene groups reflecting
the memberships to pre-defined biological pathways) and the known outcome
of interest is used to train the models, which is not the case for unsupervised
clustering.
2 Approach
Due to the flexibility of the kernel functions, methods that can handle multiple
input kernel matrices allow the integration of very distinct data types, such as
numerical, sequence, or graph data, as well as the integration of different pre-
processings of the input data. Additionally, the individual up- or downweighting
of kernel matrices can account for differences in the quality or relevance of the
kernel matrices. However, the features within one data type can be very het-
erogeneous and might not all be equally important to a meaningful distance
measure between the patients. Moreover, for non-linear kernels in general, it is
not straightforward how to identify feature importances related to the result.
Here, we propose a procedure that combines feature clustering with sample clus-
tering based on multiple kernels, thereby increasing the potential to interpret
the result without losing the power of the multiple kernel learning approach.
As illustrated in Figure 1, we cluster the features of each data type using
k-means such that we can generate one kernel matrix based on each feature clus-
ter. The kernel matrices are then integrated using a multiple kernel learning
approach, here regularized multiple kernel learning for locality preserving pro-
jection. Based on the low-dimensional projection, we cluster the samples using
fuzzy c-means. Our approach provides two advantages compared to standard
procedures. First, increasing the homogeneity of the features by identifying
feature clusters can reduce the noise in each kernel matrix, this way, a signal
that is generated by only a few features can still significantly influence the final
result if these features behave very similarly over a subset of samples. Second,
the availability of the feature clusters and respective kernel weights allows for
increased interpretability of the identified patient clusters as each cluster can
be traced back to those groups of features that had the highest influence on the
sample similarities. To our knowledge, this is the first extension of a multiple
kernel clustering algorithm towards integrative biclustering, where biclustering
describes the simultaneous clustering of features and samples, or of rows and
columns of a data matrix (Hartigan, 1972).
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Figure 1: Overview of the presented approach for two input data matrices.
First, feature clustering is performed, here with C = 3. Each feature cluster
gives rise to one kernel matrix, which are integrated using rMKL-LPP. This
method optimizes one weight for each kernel matrix and a projection matrix,
leading to a low-dimensional representation of the samples. Using these learned
coordinates, the samples are clustered using fuzzy c-means. Finally, the feature
clusters, kernel weights per feature cluster, and the patient clusters are used
to calculate FIPPA scores, which describe feature cluster impact on a patient
cluster.
3 Materials and methods
3.1 Regularized multiple kernel learning for locality pre-
serving projections (rMKL-LPP)
Given a set of M kernel matrices {K1, ...,KM} that are based on N samples.
Multiple kernel learning describes the optimization of a specific weight β for
each kernel matrix, such that an ensemble kernel matrix K can be calculated
via:
K =
M∑
m=1
βmKM , with βm ≥ 0. (1)
Regularized multiple kernel learning for locality preserving projections (Speicher
and Pfeifer, 2015) optimizes these kernel weights together with a projection
matrix such that local neighborhoods are preserved optimally when reducing
the dimensionality of the data. The projection matrix A ∈ Rp×N and the
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kernel weights β ∈ RM are learned via the minimization problem
minimize
A,β
N∑
i,j=1
‖ATK(i)β −ATK(j)β‖2wij (2)
subject to
N∑
i=1
‖ATK(i)β‖2dii = const. (3)
‖β‖1 = 1 (4)
βm ≥ 0,m = 1, 2, ...,M. (5)
with
K(i) =
K1(1, i) · · · KM (1, i)... . . . ...
K1(N, i) · · · KM (N, i)
 ∈ RN×M . (6)
The projection matrix A consists of p vectors [α1 · · ·αp] that project the
data into p dimensions. The weight matrix W and the diagonal matrix D are
determined by locality preserving projections using the k-neighborhood Nk(j)
of a sample j as follows
wij =
{
1, if i ∈ Nk(j) ∨ j ∈ Nk(i)
0, else
(7)
and dii =
∑
i6=j
wij . (8)
The optimization of A and β is performed using coordinate descent. A is op-
timized by solving a generalized eigenvalue problem, whereas the optimal β is
identified using semidefinite programming.
3.2 Fuzzy c-means clustering (FCM)
Given a data matrix X ∈ RN×l describing N samples xi with l features, FCM
identifies C cluster centers vc and assigns the degrees of memberships ui,c for
each sample i and cluster c by minimization of the following objective func-
tion (Dunn, 1974; Bezdek, 1981):
J(U, v) =
N∑
i=1
C∑
c=1
ufi,c‖xi − vc‖2 (9)
subject to
C∑
c=1
ui,c = 1 ∀i
ui,c ≥ 0 ∀i, c
N∑
i=1
ui,c > 0 ∀c.
6
The resulting U is an N ×C matrix of the degrees of cluster memberships ui,c,
which depends on f ≥ 1, a parameter of the method that controls the degree of
fuzzification. Choosing f = 1 results in the hard clustering of the samples (i.e.,
ui,c ∈ {0, 1}); choosing f →∞ results in uniform cluster probabilities ui,c = 1/C
for all i, j.
3.3 Increased interpretability due to simultaneous clus-
tering of features and samples
The impact of each feature cluster m ∈ {1, ..,M} on each identified sample
cluster c ∈ {1, ..., C} (FIPPAc,m) can be calculated based on the kernel weights
β and the kernel matrices Km using the following equation
FIPPAc,m =
1
|c|2
∑
xi,xj∈c
βmKm[i, j]
K[i, j]
, (10)
with K being the ensemble kernel matrix. Here, we suppose a hard clustering of
the patients, which can either be generated using a hard clustering algorithm or
using the modal class of a fuzzy clustering. However, fuzzy clustering provides
additional information concerning the reliability of the cluster assignment for
each sample. Using these probabilities can make the results more robust given
that some samples might have an ambiguous signature and therefore lie between
two or more clusters. Given a probability pc(xi) = p(xi ∈ c) that patient xi
belongs to cluster c, the fuzzy FIPPA can be calculated as follows:
fFIPPAc,m =
1
|N |2
N∑
i,j=1
pc(xi)pc(xj)
βmKm[i, j]
K[i, j]
. (11)
The incorporation of the joint probability p(xi ∈ c ∧ xj ∈ c) = pc(xi)pc(xj)
replaces the selection of sample pairs performed in Equation 10 but still allows
to downweight the effects of samples that are uncertain or unlikely to belong to
c.
Moreover, we can separate this overall score into a positive part (fFIPPA+k,m)
that leads to high intra-cluster similarity and a negative part that leads to high
inter-cluster (fFIPPA−k,m) dissimilarity. For this purpose, we define
K+ =
M∑
m=1
βmK
+
m and K− =
M∑
m=1
βmK
−
m (12)
with K+m being the positive part of the matrix Km (all negative values set
to zero) and vice versa for K−m. For this step, all kernel matrices need to be
centered in the feature space, such that the mean of each matrix is equal to zero.
When combining Formula 12 with Formula 11, the calculation of the positive
7
and negative fFIPPA is given by
fFIPPA+c,m =
1
|N |2
N∑
i,j=1
pc(xi ∧ xj)βmK
+
m[i, j]
K+[i, j]
, and
fFIPPA−c,m =
1
|N |2
N∑
i,j=1
pc(xi ⊕ xj)βmK
−
m[i, j]
K−[i, j]
. (13)
Besides the fact that the two scores are based on the positive and the negative
part of the kernel matrices, respectively, the main difference between them is
the probability factor for each summand. For the positive fFIPPA, the joint
probability pc(xi ∧ xj) is used to generate high influence for pairs where both
partners are likely to belong to cluster c, while for the negative fFIPPA, the
exclusive or, defined by
pc(xi ⊕ xj) = (pc(xi) + pc(xj)− 2pc(xi)pc(xj)), (14)
results in an increased factor for pairs of samples of which exactly one has a
high probability for c.
The fFIPPA scores calculated allow the identification of feature clusters that
contribute more than average to the similarity of the samples within a sample
cluster and the dissimilarity of the samples in two different clusters, thereby,
revealing the underlying basis of the generated clustering.
3.4 Materials
We applied our approach to six different cancer data sets generated by The Can-
cer Genome Atlas which were downloaded from the UCSC Xena browser (Gold-
man et al., 2017). The cancer types covered are breast invasive carcinoma
(BRCA), lung adenocarcinoma (LUAD), head and neck squamous cell carci-
noma (HNSC), lower grade glioma (LGG), thyroid carcinoma (THCA) and
prostate adenocarcinoma (PRAD). For each cancer patient, we used DNA methy-
lation, gene expression data, copy number variations, and miRNA expression
data for clustering. DNA methylation was mapped from methylation sites to
gene promoter and gene body regions using RnBeads (Assenov et al., 2014).
Using GeneTrail (Sto¨ckel et al., 2016), we mapped the miRNAs to their target
genes (i.e., the gene that is regulated by the miRNA) such that the features
of each data type were genes. Due to the high number of features available,
we performed the whole analysis on the 10% of the features with the highest
variance from each data type. For the cluster evaluation, we further leveraged
the survival times of the patients for all cancer types except PRAD and THCA.
For these two cancer types, survival analysis would not be informative due to
the low number of events.
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4 Results and discussion
4.1 Parameter selection
When applying our approach to a data set, we need to choose the number of fea-
ture clusters per data type as well as the number of patient clusters. For our ex-
perimental validation, we set both parameters to the same value (c ∈ {2, ..., 6}).
Feature clustering was performed using k-means before generating the kernel
matrices using the Gaussian radial basis kernel function. The parameter of the
kernel γ was chosen dependent on the number of features d in the respective fea-
ture set based on the rule of thumb γ = 12d2 (Ga¨rtner et al., 2002). We generated
three kernels per data type by multiplying this γ with a factor fγ ∈ {0.5, 1, 2}
and only used the one kernel matrix providing the highest variance in the first d
principal components. The number of neighbors for rMKL-LPP was set to 9 and
the the number of dimensions d to 5, as explained in our previous work (Speicher
and Pfeifer, 2015). The fuzzification degree f of the soft-clustering algorithm
was set to the default value of 2 in concordance with Dunn (1974). If neces-
sary for the subsequent analysis, we assigned each patient to its modal cluster
(i.e., the cluster with the highest probability), otherwise, we used the cluster
membership probabilities returned by FCM.
4.2 Robustness
Since each kernel matrix in this approach is constructed on the basis of a feature
cluster, slight changes in these initial clusters will propagate through the algo-
rithm and might have an effect on the final result. We repeated the complete
approach 50 times with different seeds to analyze the robustness of the final
patient clustering. Figure 2 shows the pairwise similarities measured by the
Rand index between the final patient clusterings. When including all patients
according to their modal class, we observe high reproducibility for all cancer
types except LUAD, for which the Rand index is approx. 0.85. When using
the class probabilities for each sample to exclude patients where the prediction
has a low confidence, here defined as being more than one standard deviation
lower than the mean, we observe that the cluster assignments for the remaining
patients are more stable for all cancer types including LUAD.
4.3 Survival analysis
To evaluate if a patient clustering could be clinically relevant, we performed
survival analysis on the results with C ∈ {2, ..., 6} clusters for each cancer type.
To assess the influence of the feature clustering step, we also generated patient
clusterings with two established methods: kLPP with the average kernel, and
rMKL-LPP without feature clustering, which has been shown to perform well in
comparison to other data integration methods (Rappoport and Shamir, 2018).
To obtain a fair comparison, the same kernel matrices have been used for all
approaches.
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Figure 2: Robustness of FC+rMKL-LPP in 50 repetitions. Dark grey boxes
indicate Rand indices on the basis of all patients, light grey boxes indicate
Rand indices calculated without low confidence samples, i.e., patients with a
modal class probability pc more than one standard deviation smaller than the
mean of the modal class probabilities.
Table 1: For each cancer type and method, we report the most significant
results when varying the number of clusters from two to six. Average kLPP
stands for kernel locality preserving projection on the (unweighted) average
kernel, rMKL-LPP for the standard multiple kernel learning approach with one
kernel per data type, and FC + rMKL-LPP represents the proposed approach
for which the reported p-values are the median of 50 runs. All three approaches
are combined with subsequent fuzzy c-means clustering. C indicates the chosen
number of clusters.
Cancer average kLPP rMKL-LPP FC + rMKL-LPP
p-value C p-value C p-value C
BRCA 3.7E-2 6 7.3E-2 6 5.0E-2 4
HNSC 1.4E-3 6 1.4E-3 6 9.96E-3 5
LGG <1.0E-16 3:6 <1.0E-16 3:6 <1.0E-16 3:6
LUAD 0.15 2 2.9E-2 2 3.1E-2 6
The p-value for the log-rank test (Hosmer Jr. et al., 2011) indicates if there
is at least one group of patients among the identified ones with a significant
difference in the survival rate compared to the other groups. While the number
of clusters is reflected in the degrees of freedom that are used in the test, we
still corrected for the number of tests performed due to the variation of C us-
ing Benjamini-Hochberg correction. The results of the survival analysis shown
10
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(a) fFIPPA scores for intra-cluster similarity of the patient clusters.
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(b) fFIPPA scores for inter-cluster dissimilarity of the patient clusters.
Figure 3: Positive and negative fFIPPA of each feature cluster and
patients cluster for BRCA with C = 4. Each row represents one patient
cluster, i.e., it is derived using the probabilities for this specific cluster. The
width of a bar segment is defined by fFIPPA+c,m or (fFIPPA
−
c,m) for the respective
patient cluster c and feature cluster m.
in Table 1 indicate that on the four cancer types where the number of events
allows for a survival analysis, our approach has a comparable performance to
the established methods and is able to find biologically meaningful groups of
patients. Moreover, despite the additional flexibility which is achieved by the
feature clustering, the optimal number of clusters does not increase in compar-
ison to less complex methods. However, as not all patients receive an optimal
treatment, the survival data can be biased. Therefore, we need additional means
to evaluate and interpret the underlying structure of the identified clusterings.
4.4 Interpretation
As described in Section 3.3 the weights for each feature cluster in combination
with the kernel matrices allow us to calculate the fFIPPA scores. Figure 3(a)
visualizes the positive fFIPPA scores for the BRCA clustering with c = 4. Here,
we can see clear differences between the patient clusters. While for all of them,
copy number variations have the strongest impact, the exact contributions of
the data types vary (e.g. the fFIPPA of gene expression, especially feature
cluster 3, is strongest in patient cluster 3). When comparing to the negative
fFIPPAs (cf. Figure 3(b)), we observe in general similar patterns. Differences
still occur, e.g., in patient cluster 2 and 4, one can see that the fFIPPA of copy
number variations on the intra-cluster similarity is larger than their impact on
inter-cluster dissimilarity.
Observing the impact of each data type is also possible with traditional
multiple kernel learning, however, in our approach, we can additionally analyze
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the impact of the individual feature clusters. To gain further insights into the
underlying biological mechanisms, we used the positive and negative fFIPPA
scores to identify which feature clusters contributed more than average to a
patient cluster, i.e., we initialized two lists of feature clusters, the first one
explaining high dissimilarity to other patient clusters, the second one explaining
high similarity within the patient cluster. After identification of these high-
fFIPPA feature clusters, we filtered the associated features to keep only those
that behave homogeneously over the patients of the specific cluster. For the
homogeneity filtering, we introduced a homogeneity score, counting in how many
patients of the respective patient cluster the gene was constantly expressed (i.e.,
either over- or underexpressed, whichever happened more often). Based on these
scores, we obtained a distribution representing the homogeneity of the features
within a cluster. For further analysis, we kept every gene with a score larger than
the mean of this distribution and distinguish between over- and underexpressed
genes. This way, we generated four lists of features for each patient cluster
describing a) overexpressed genes leading to high intra-cluster similarity, b)
underexpressed genes leading to high intra-cluster similarity, c) overexpressed
genes leading to high inter-cluster dissimilarity and d) underexpressed genes
leading to high inter-cluster dissimilarity.
In these lists, we found genes with known implications to cancer formation or
progression. Some of the genes were related to several cancer types (e.g. PTEN,
which regulates the AKT/PKB signaling pathway and thereby represents a
tumor suppressor in various tumors (Cantley and Neel, 1999) was present in
lists for BRCA, THCA, and PRAD) or to several clusters of the same cancer
type (e.g.SOX2 for HNSC, which has been shown to control tumor initiation
in squamous-cell carcinomas (Boumahdi et al., 2014)). Others were only found
for one specific cluster of a cancer type (e.g., among the four clusters of BRCA,
only one gene list included GRPR, a G-protein coupled receptor that was shown
to influence the viability of breast cancer cells (Cornelio et al., 2013)). From a
biological perspective, this finding is consistent with our expectation that the
lists are not disjoint, since cancer does not form due to an individual mutation
but rather as a consequence of a number of different aberrations, which can be
shared between different subtypes or even cancer types.
Besides looking at the lists at the level of individual genes, we also inferred
biological functions that are related to these gene lists using GeneTrail (Sto¨ckel
et al., 2016). We applied over-representation analysis which tests, if significantly
more genes in the list are associated to a specific category than would be ex-
pected based on a background gene list. As background all the genes were used
that entered the clustering and we tested for enrichment of KEGG pathways
and gene ontology categories (GO).
As there was some variation in the cluster assignments, one would also expect
some variation in the enriched terms. To quantify the stability of the result,
we compared the identified terms of the best to the terms of the median result,
where best and median was defined according to the survival p-value. The
similarity of the GO terms was determined using the relevance score Schlicker
et al. (2006), for the similarity between two sets of KEGG pathways we used
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the Jaccard index. The average similarities correlate to the observed stabilities
of the cluster assignments: The value for LUAD is slightly lower than for BRCA
and HNSC (0.48 vs. 0.58 and 0.68, respectively), however, for all three cancer
types the scores indicate that similar functions or pathways are found. For LGG,
the results were stable such that the optimum and median were equivalent, for
PRAD and THCA, the best and median result could not be identified due to
the lack of adequate survival data.
Based on the intersection of the optimal and median result, Table 2 shows a
subset of the findings for HNSC for Cluster 3, which has the poorest prognosis
(median survival time 1079 days), and Cluster 4, which has the best prognosis
(median survival time > 4241 days). The terms identified are very different
for the two clusters. In Cluster 3, we obtained enriched terms that are mainly
associated with muscle cells, more specifically, their development or their acti-
vation. Skeletal muscle invasion seems to be correlated to the recurrence of the
disease (Chandler et al., 2011), which agrees with our observation that patients
having a distinct signature in the genes involved in these functions have a poor
survival. For patient cluster 4, we identified terms related to the phosphoryla-
tion of a STAT protein which regulates as a part of the JAK/STAT signaling
pathway cell growth and has been shown to play a role in tumor formation
and progression (Song and Grandis, 2000). On the other hand, the identified
terms mainly refer to functions of the immune system, including the regulation
of type I interferon mediated signaling pathway which is a regulation of the in-
nate immune response. Despite of the controversial role of inflammation and
the immune system in cancer (Coussens and Werb, 2002), its activation could
help eliminate cancer cells and therefore, be beneficial for the respective patient
group. For HNSC, the terms associated to high inter-cluster dissimilarity and
high intra-cluster similarity differ only for Cluster 1, where we identify terms,
such as B cell differentiation and proliferation, that are associated to high dis-
similarity to other clusters but not to high intra-cluster similarity.
We also applied our approach to PRAD and THCA where survival anal-
ysis is not meaningful because only a small number of patients die from the
disease. For both cancer types, we set C to 4 and could identify different signif-
icant terms for some patient clusters. For PRAD, we identified amongst others
a number of terms related to the activity of olfactory receptors, which have
been shown to participate in the process of tumor cell proliferation and apopto-
sis (Chen et al., 2018). Several hits for THCA, e.g., DNA deamination, indicate
an influence of epigenetic regulation mechanisms, which is supported by current
literature (Rodr´ıguez-Rodero et al., 2017).
5 Conclusion
The approach presented in this paper provides a step towards a better inter-
pretabilty of multiple kernel clustering. For a few kernel functions it is possible
to extract feature importances, however, our new procedure is independent of
the kernel function used and can consequently be applied in combination with
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Table 2: Significant GO terms and KEGG pathways associated with high intra-
cluster similarity identified by over-representation analysis for patient clusters
3 and 4 for HNSC. For patient cluster 3, the terms are based on inactive genes,
for patient cluster 4 on active genes.
c = 3 GO-Cellular component (p-value < 1.0E − 3)
contractile fiber
myofibril
sarcomere
I band
myosin II complex
muscle myosin complex
A band
myosin complex
Z disc
myofilament
GO - Biological Process (p-value < 1.0E − 3)
myofibril assembly
striated muscle cell development
muscle filament sliding&actin myosin filament sliding
striated muscle contraction
actomyosin structure organization
muscle cell development
c = 4 GO -Biological process (p-value < 1.0E − 3)
regulation of peptidyl serine phosphorylation of STAT protein
natural killer cell activation involved in immune response
serine phosphorylation of STAT protein
response to exogenous dsRNA
natural killer cell activation
positive regulation of peptidyl serine phosphorylation
regulation of type I interferon mediated signaling pathway
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any kernel function. The application to biological data sets shows that the
approach gives state-of-the-art performance with respect to survival analysis.
Additionally, the weights for the feature clusters can be used to extract mean-
ingful information describing the individual sample clusters identified, thereby,
leading to comprehensive insights on individual subtypes which allows to gener-
ate hypotheses that can be specifically tested. The initial screening for overlap
between the found information and biological literature shows very promising
results.
In our current approach, the feature clusters influence the patient clusters
but not vice versa. As shown on biological examples, these feature groups
already provide valuable information. However, to obtain feature clusters, that
are even more specific to the patient clusters, simultaneous optimization of
feature and patient clusters could be beneficial. Also are the feature clusters
currently restricted to be non-overlapping and to include every feature. In many
real-world scenarios we might want to a more flexible approach that is relaxing
these constraints.
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